| Literature DB >> 33021770 |
Maxim B Freidin1, Yakov A Tsepilov2,3, Ian B Stanaway4, Weihua Meng5, Caroline Hayward6, Blair H Smith5, Samar Khoury7,8,9, Marc Parisien7,8,9, Andrey Bortsov10, Luda Diatchenko7,8,9, Sigrid Børte11,12,13, Bendik S Winsvold12,13, Ben M Brumpton13, John-Anker Zwart11,12,13, Yurii S Aulchenko2,3,14, Pradeep Suri15,16,17, Frances M K Williams1.
Abstract
ABSTRACT: Sex differences for chronic back pain (cBP) have been reported, with females usually exhibiting greater morbidity, severity, and poorer response to treatment. Genetic factors acting in an age-specific manner have been implicated but never comprehensively explored. We performed sex- and age-stratified genome-wide association study and single nucleotide polymorphism-by-sex interaction analysis for cBP defined as "Back pain for 3+ months" in 202,077 males and 237,754 females of European ancestry from UK Biobank. Two and 7 nonoverlapping genome-wide significant loci were identified for males and females, respectively. A male-specific locus on chromosome 10 near SPOCK2 gene was replicated in 4 independent cohorts. Four loci demonstrated single nucleotide polymorphism-by-sex interaction, although none of them were formally replicated. Single nucleotide polymorphism-explained heritability was higher in females (0.079 vs 0.067, P = 0.006). There was a high, although not complete, genetic correlation between the sexes (r = 0.838 ± 0.041, different from 1 with P = 7.8E-05). Genetic correlation between the sexes for cBP decreased with age (0.858 ± 0.049 in younger people vs 0.544 ± 0.157 in older people; P = 4.3E-05). There was a stronger genetic correlation of cBP with self-reported diagnosis of intervertebral disk degeneration in males than in females (0.889 vs 0.638; P = 3.7E-06). Thus, the genetic component of cBP in the UK Biobank exhibits a mild sex- and age-dependency. This provides an insight into the possible causes of sex- and age-specificity in epidemiology and pathophysiology of cBP and chronic pain at other anatomical sites.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33021770 DOI: 10.1097/j.pain.0000000000002100
Source DB: PubMed Journal: Pain ISSN: 0304-3959 Impact factor: 6.961